633 related articles for article (PubMed ID: 26860266)
1. Breakthroughs in the treatment and prevention of Clostridium difficile infection.
Kociolek LK; Gerding DN
Nat Rev Gastroenterol Hepatol; 2016 Mar; 13(3):150-60. PubMed ID: 26860266
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of
Eliakim-Raz N; Bishara J
Hum Vaccin Immunother; 2019; 15(6):1453-1456. PubMed ID: 29781761
[TBL] [Abstract][Full Text] [Related]
3. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Lv Z; Peng G; Liu W; Xu H; Su J
Antimicrob Agents Chemother; 2015 Jul; 59(7):3726-35. PubMed ID: 25824219
[TBL] [Abstract][Full Text] [Related]
4. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection: A brief update on emerging therapies.
Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
[TBL] [Abstract][Full Text] [Related]
6. The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with
Džunková M; D'Auria G; Xu H; Huang J; Duan Y; Moya A; Kelly CP; Chen X
Front Cell Infect Microbiol; 2016; 6():119. PubMed ID: 27757389
[TBL] [Abstract][Full Text] [Related]
7. Update of treatment algorithms for Clostridium difficile infection.
Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
[TBL] [Abstract][Full Text] [Related]
8. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.
Gerding DN; Meyer T; Lee C; Cohen SH; Murthy UK; Poirier A; Van Schooneveld TC; Pardi DS; Ramos A; Barron MA; Chen H; Villano S
JAMA; 2015 May; 313(17):1719-27. PubMed ID: 25942722
[TBL] [Abstract][Full Text] [Related]
9. The potential for emerging therapeutic options for Clostridium difficile infection.
Mathur H; Rea MC; Cotter PD; Ross RP; Hill C
Gut Microbes; 2014; 5(6):696-710. PubMed ID: 25564777
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of refractory or recurrent Clostridium difficile infection].
Kim SW
Korean J Gastroenterol; 2012 Aug; 60(2):71-8. PubMed ID: 22926117
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
12. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
Lancaster JW; Matthews SJ
Clin Ther; 2012 Jan; 34(1):1-13. PubMed ID: 22284993
[TBL] [Abstract][Full Text] [Related]
13. Management of Clostridium difficile infection: thinking inside and outside the box.
Gerding DN; Johnson S
Clin Infect Dis; 2010 Dec; 51(11):1306-13. PubMed ID: 20979491
[TBL] [Abstract][Full Text] [Related]
14. Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.
Jain T; Croswell C; Urday-Cornejo V; Awali R; Cutright J; Salimnia H; Reddy Banavasi HV; Liubakka A; Lephart P; Chopra T; Revankar SG; Chandrasekar P; Alangaden G
Biol Blood Marrow Transplant; 2016 Jan; 22(1):157-63. PubMed ID: 26211988
[TBL] [Abstract][Full Text] [Related]
15. Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic.
Sears P; Ichikawa Y; Ruiz N; Gorbach S
Ann N Y Acad Sci; 2013 Jul; 1291():33-41. PubMed ID: 23672600
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection prevention: biotherapeutics, immunologics, and vaccines.
Gerding DN
Discov Med; 2012 Jan; 13(68):75-83. PubMed ID: 22284786
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of Clostridium difficile in adults: a systematic review.
Bagdasarian N; Rao K; Malani PN
JAMA; 2015 Jan; 313(4):398-408. PubMed ID: 25626036
[TBL] [Abstract][Full Text] [Related]
18. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537
[No Abstract] [Full Text] [Related]
19. Challenges and opportunities in the management of Clostridium difficile infection.
DuPont HL
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):863-74. PubMed ID: 25012255
[TBL] [Abstract][Full Text] [Related]
20. Use of probiotics in prevention and treatment of patients with Clostridium difficile infection.
Ollech JE; Shen NT; Crawford CV; Ringel Y
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):111-8. PubMed ID: 27048902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
